Tae Il Kim (Tae-Il Kim)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 33

Top Venues

Cancers

Gut and liver

Yonsei medical journal

Journal of gastroenterology and hepatology

Yonsei University College of Medicine

Yonsei University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Yonsei University College of Medicine Mar 01 2002

South Korea

Professor :: Gastroenterology, Internal Medicine

Education History

Yonsei University College of Medicine Sep 01 1995 - Feb 28 2002

South Korea

PHD :: Internal Medicine, Gastroenterology

Publications

Yoojeong Seo, Dong Keon Kim, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O -GlcNAcylation in Colorectal Cancer. Cancers 16 (5) (2024)
Yoojeong Seo, Dong Keon Kim, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
A Comprehensive Understanding of Post-Translational Modification of Sox2 via Acetylation and O -GlcNAcylation in Colorectal Cancer. Cancers 16 (5) (2024)
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease. Journal of gastroenterology and hepatology 39 (3) (2023)
Hye Kyung Hyun, Hye-Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do-Young Kim, Sang Hoon Ahn, Seung-Up Kim, Jae Hee Cheon
Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease. Gut and liver (2023)
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease. Journal of gastroenterology and hepatology (2023)
So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy. Yonsei medical journal 64 (2) (2023)
Eun Jin Yoo, Sang-Hoon Cho, Soo Jung Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Characteristics and Treatment Outcomes of Transition among Patients with Inflammatory Bowel Disease. Yonsei medical journal 64 (9) (2023)
So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy. Yonsei medical journal 64 (2) (2023)
Ji Young Chang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Hee Cheon, Jihye Park
Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease. Journal of gastroenterology and hepatology 39 (3) (2023)
Hyo-Min Kim, Byunghee Kang, Sohyun Park, Hyorim Park, Chan Johng Kim, Hyeonji Lee, Mijoung Yoo, Mi-Na Kweon, Sin-Hyeog Im, Tae Il Kim, Tae-Young Roh
Forkhead box protein D2 suppresses colorectal cancer by reprogramming enhancer interactions. Nucleic acids research (2023)
So Jung Han, Eun Ae Kang, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Risk Factors for Surgery in Patients with Intestinal Behçet's Disease During Anti-Tumor Necrosis Factor-Alpha Therapy. Yonsei medical journal 64 (2) (2023)
Hyun Woo Ma, Jung Min Kim, Da Hye Kim, I Seul Park, Ji Hyung Kim, Ki-Cheong Park, Dong Hyuk Seo, Jae Hyeon Kim, Xiumei Che, Tae Il Kim, Jae Hee Cheon, Seung Won Kim
Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer. Cancer gene therapy (2022)
Hyun Woo Ma, Jung Min Kim, Da Hye Kim, I Seul Park, Ji Hyung Kim, Ki-Cheong Park, Dong Hyuk Seo, Jae Hyeon Kim, Xiumei Che, Tae Il Kim, Jae Hee Cheon, Seung Won Kim
Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer. Cancer gene therapy (2022)
Joyeon Kang, Doyeon Lee, Kyoung Jin Lee, Jaepil Eric Yoon, Ji-Hee Kwon, Yoojeong Seo, Janghyun Kim, Shin Young Chang, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Tae Il Kim
Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer. Cancers 14 (12) (2022)
Yuna Kim, Jae Hyun Kim, Eun-Ae Kang, Soo-Jung Park, Jae-Jun Park, Jae-Hee Cheon, Tae Il Kim, Jihye Park, Seong-Ran Jeon
Rebleeding Rate and Risk Factors for Rebleeding after Device-Assisted Enteroscopy in Patients with Obscure Gastrointestinal Bleeding: A KASID Multicenter Study. Diagnostics (Basel, Switzerland) 12 (4) (2022)
Ji Hyun Lee, Su-Jin Shin, Eun-Ah Choe, Jungyoun Kim, Woo Jin Hyung, Hyo Song Kim, Minkyu Jung, Seung-Hoon Beom, Tae Il Kim, Joong Bae Ahn, Hyun Cheol Chung, Sang Joon Shin
Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 14 (11) (2022)
Ji Hyun Lee, Su-Jin Shin, Eun-Ah Choe, Jungyoun Kim, Woo Jin Hyung, Hyo Song Kim, Minkyu Jung, Seung-Hoon Beom, Tae Il Kim, Joong Bae Ahn, Hyun Cheol Chung, Sang Joon Shin
Correction: Lee et al. Tropomyosin-Related Kinase Fusions in Gastrointestinal Stromal Tumors. Cancers 2022, 14 , 2659. Cancers 14 (22) (2022)
Sung Chul Park, Byung Chang Kim, Sung Pil Hong, Yoojeong Seo, Hye Sun Lee, Soo-Young Na, Jong Ha Park, Chang Mo Moon, Kyu Chan Huh, Jae Hee Cheon, Tae Il Kim
The Effect of Metformin in Treatment of Adenomas in Patients with Familial Adenomatous Polyposis. Cancer prevention research (Philadelphia, Pa.) 14 (5) (2021)
Bun Kim, Yoojeong Seo, Ji-Hee Kwon, Youmi Shin, Suhyun Kim, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
IL-6 and IL-8, secreted by myofibroblasts in the tumor microenvironment, activate HES1 to expand the cancer stem cell population in early colorectal tumor. Molecular carcinogenesis 60 (3) (2021)
Jung Won Park, Soo Yeon Chang, Joon Seok Lim, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Byung Chang Kim, Tae Il Kim
Impact of Visceral Fat on Survival and Metastasis of Stage III Colorectal Cancer. Gut and liver (2021)
Hee Eun Kang, Yoojeong Seo, Jun Seop Yun, Sang Hyun Song, Dawool Han, Eunae Sandra Cho, Sue Bean Cho, Yoon Jeon, Ho Lee, Hyun Sil Kim, Joyeon Kang, Jong-In Yook, Nam Hee Kim, Tae Il Kim
Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer. Cancers 13 (14) (2021)
Jongwook Yu, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Prognostic Value of Terminal Ileal Inflammation in Patients with Ulcerative Colitis. Gut and liver 15 (6) (2021)
Yong Il Lee, Ye Hyun Park, Soo Jung Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Comparison of Long-Term Outcomes of Infliximab versus Adalimumab Treatment in Biologic-Naïve Patients with Ulcerative Colitis. Gut and liver 15 (2) (2021)
Jongwook Yu, Hye Kyung Hyun, Jihye Park, Eun Ae Kang, Soo Jung Park, Jae Jun Park, Tae Il Kim, Byung Chang Kim, Jae Hee Cheon
Continued Postoperative Use of Tumor Necrosis Factor-α Inhibitors for the Prevention of Crohn's Disease Recurrence. Gut and liver (2021)
Ja Seol Koo, Seung Wook Hong, Bo In Lee, Sung Ae Jung, Tae Il Kim, Yoon Tae Jeen
Efficacy and Safety of TJP-008 Compared to 2 L PEG with Ascorbate in Colon Cleansing: A Randomized Phase 3 Trial. Gut and liver (2021)
Yong-Hee Cho, Eun Ji Ro, Jeong-Su Yoon, Tomohiro Mizutani, Dong-Woo Kang, Jong-Chan Park, Tae Il Kim, Hans Clevers, Kang-Yell Choi
5-FU promotes stemness of colorectal cancer via p53-mediated WNT/β-catenin pathway activation. Nature communications 11 (1) (2020)
Yoojeong Seo, Janghyun Kim, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Won Ho Kim, Tae Il Kim
Metformin Suppresses Cancer Stem Cells through AMPK Activation and Inhibition of Protein Prenylation of the Mevalonate Pathway in Colorectal Cancer. Cancers 12 (9) (2020)
Ji Young Chang, Jae Hyun Kim, Joyeon Kang, Ye Hyun Park, Soo Jung Park, Jae Hee Cheon, Byung Chang Kim, Hoguen Kim, Jae Jun Park, Tae Il Kim
mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer. Yonsei medical journal 61 (7) (2020)
Jae Hwang Cha, Da Hyun Jung, Jie-Hyun Kim, Young Hoon Youn, Hyojin Park, Jae Jun Park, Yoo Jin Um, Soo Jung Park, Jae Hee Cheon, Tae Il Kim, Won Ho Kim, Hyun Jung Lee
Long-term outcomes according to additional treatments after endoscopic resection for rectal small neuroendocrine tumors. Scientific reports 9 (1) (2019)
Hyun Jung Lee, Jae Hyeon Kim, Sujeong Hong, Inhwa Hwang, Soo Jung Park, Tae Il Kim, Won Ho Kim, Je-Wook Yu, Seung Won Kim, Jae Hee Cheon
Proteomics-based functional studies reveal that galectin-3 plays a protective role in the pathogenesis of intestinal Behçet's disease. Scientific reports 9 (1) (2019)
Won Kyu Kim, Yujin Kwon, Mi Jang, Minhee Park, Jiyoon Kim, Suyeon Cho, Dong Geon Jang, Wook-Bin Lee, Sang Hoon Jung, Hye Jin Choi, Byung Soh Min, Tae Il Kim, Sung Pil Hong, Young-Ki Paik, Hoguen Kim
β-catenin activation down-regulates cell-cell junction-related genes and induces epithelial-to-mesenchymal transition in colorectal cancers. Scientific reports 9 (1) (2019)
Yoon Suk Jung, Jung Ho Park, Dong Il Park, Chong Il Sohn, Jae Myun Lee, Tae Il Kim
Physical Inactivity and Unhealthy Metabolic Status Are Associated with Decreased Natural Killer Cell Activity. Yonsei medical journal 59 (4) (2018)
Jihye Park, Jae Hyun Kim, Yehyun Park, Soo Jung Park, Jae Hee Cheon, Won Ho Kim, Ji Soo Park, Justin Y Jeon, Tae Il Kim
Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence. PloS one 13 (3) (2018)

Tae Il Kim.css-eqlu8i{font-size:small;padding-left:4px;} (Tae-Il Kim)

Publication Activity (10 Years)

Top Topics

Top Venues

Tae Il Kim (Tae-Il Kim)